Prescription Drug Comparative Effectiveness Act of 2006 - Requires the Director of the Agency for Healthcare Research and Quality (AHRQ) to conduct or support reviews of existing evidence and research to develop evidence regarding comparative clinical effectiveness, outcomes, and appropriateness of prescription drugs, medical devices, and procedures.
Requires the Secretary of Health and Human Services to develop a coordinated plan for research on methods for measuring and comparing adverse events associated with pharmaceuticals and other medical and surgical treatments so that clinicians and patients can evaluate the comparative safety and clinical effectiveness of the alternative treatment options.
Provides for information developed from such reviews to be made available to practitioners and patients.